CHPA to fight reverse-switch of PSE products in Mississippi with legislative line
JACKSON, Miss. The Consumer Healthcare Products Association on Saturday announced a legislative line for consumers to call in an effort to fight a move to reverse-switch cold and allergy medicines containing pseudoephedrine from behind-the-counter to prescription-only.
"CHPA has provided a phone number for Mississippians to contact their legislators which within the first day fielded scores of calls from around the state,” stated CHPA spokeswoman Elizabeth Funderburk. “We have heard their outrage on talk radio, and online posting to news web pages. And recent polling shows almost two-thirds of Mississippi voters oppose the legislation,” she said. “Everyone wants to fight meth, but Mississippians believe an electronic tracking procedure is better than the added cost and burden of a prescription mandate.”
According to the poll, 74% of Mississippi consumers agree that an Rx-only requirement would create an "unnecessary burden" for law-abiding citizens, and approximately 61% oppose the law.
Last week, the Mississippi House passed H.B. 512, legislation that would impose an Rx-only mandate on commonly available cold and allergy medications containing PSE. Identical legislation is currently being shepherded through the Senate (S.B. 2339).
"Because Mississippi does not tax prescription drugs, this legislation would also divert $590,000 from the general fund annually, as well as increase the costs to Mississippi's Medicaid program through increased doctor's visits and prescriptions as a result," Funderburk added. "This would be an expensive new mandate from the state on the budgets of Mississippi families and Mississippi taxpayers. There is a better way to fight meth, and that's through establishing an electronic tracking program to stop the illegal sale to criminals."
The survey, conducted from Jan. 14 to Jan. 23, involved 350 Mississippi state residents ages 18 years and over, all of whom voted in the last election. The survey was sponsored by the Consumer Healthcare Products Association.